Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01591512 · ClinicalTrials.gov registry record
A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer
A clinical trial, sponsored by Fujirebio Diagnostics.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01591512 is a clinical trial that was terminated before completion, run by Fujirebio Diagnostics. The registered enrollment target is 4 participants.
The verdict
NCT01591512 was terminated before completion, sponsored by Fujirebio Diagnostics.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01591512
The ClinicalTrials.gov registry entry for NCT01591512 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fujirebio Diagnostics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01591512 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01591512 about?
NCT01591512 is a clinical study titled "A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer". The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.
What is the current status of trial NCT01591512?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2011-05. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT01591512?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.